-
As performance improvement programs and the ability to track data and trends from outcomes-based quality improvement reports have become more sophisticated, home health agencies report improvements in all categories, except hospital readmission rates.
-
The first year that Health Alliance Plan (HAP) offered on-site wellness programs for employer groups, the Detroit-based health plan implemented programs at 20 companies.
-
-
St. Jude Medical (St. Paul, Minnesota) reported the enrollment of the first patient in its ESCAPE (Effect of Septal Closure of Atrial PFO on Events of Migraine with Premere) migraine trial, making it the first company to begin enrollment in a U.S. clinical trial to evaluate the connection between patent foramen ovales (PFOs) and migraine headaches.
-
Biosense Webster (Diamond Bar, California), a Johnson & Johnson (New Brunswick, New Jersey) company, and Siemens Medical Solutions (Malvern, Pennsylvania) entered a strategic alliance giving Biosense Webster exclusive worldwide rights to distribute Siemens Acuson AcuNav ultrasound catheters to electrophysiologists.
-
With an environment demanding increased public disclosure of information about implantable devices, med-tech powerhouse Medtronic (Minneapolis) released its 2006 Medtronic CRM Product Performance Report (First Edition, Volume 54), incorporating up-to-date information about pacemaker, implantable cardioverter-defibrillator (ICD) and implantable lead performance.
-
Following is the list of the recommendation made to Guidant(Indianapolis) concerning strengthening its product surveillance and reporting.
-
An anniversary, especially a 10-year one, would typically be a cause for a festive celebration. However, at this year's 31st annual International Stroke Conference, sponsored by the American Stroke Association (ASA; Dallas) and held here in February, the 10th anniversary of the FDA's 1996 approval of Genentech's (South San Francisco, California) clot-busting drug tissue plasminogen activator (tPA) was noted in muted style.
-
Andrew Reed, PhD, has joined CardioTech International (Wilmington, Massachusetts) as vice president of technology in charge of CardioPass coronary artery bypass development and biomaterials.
-
Angiography for female patients who have presented with symptoms of cardiac distress appear to be not effective in determining the possible extent of coronary artery disease that may actually exist, according to new research.
